MTOR and prostate carcinoma: In prostate cancer cells, a possible target for PLT was receptor tyrosine kinase, such as S6 ribosomal protein (rpS6), a key regulator of protein synthesis and a downstream effector of the Akt/mTOR/p70S6K signaling pathway.